JAMES REBBEOR,CHARLES MILLER,ANTHONY KLOS,ERIC ALLGAIER,THOMAS P. ZIMMERMAN,KEVIN WEE,MICHELLE StPETER,KELLY GLANCY
申请号：
US16529686
公开号：
US20200038494A1
申请日:
2019.08.01
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Compositions include highly-concentrated Alpha-1 Proteinase Inhibitor (A1PI) in a concentration greater than or equal to 100 mg/ml. Pharmaceutical compositions can be prepared from these compositions. The pharmaceutical compositions can be suitable for subcutaneous administration. The highly-concentrated A1PI solutions can be obtained by single-pass tangential flow filtration (SPTFF).
